• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Proactive Engagement of the Expert Meeting in Managing the Early Phase of the COVID-19 Epidemic, Japan, February-June 2020

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2021 Oct;27(10):1-9.
doi: 10.3201/eid2710.204685.
Proactive Engagement of the Expert Meeting in Managing the Early Phase of the COVID-19 Epidemic, Japan, February-June 2020

Tomoya Saito, Kaori Muto, Mikihito Tanaka, Nobuhiko Okabe, Hitoshi Oshitani, Satoshi Kamayachi, Yoshihiro Kawaoka, Akihiko Kawana, Motoi Suzuki, Kazuhiro Tateda, Hitomi Nakayama, Masaki Yoshida, Akifumi Imamura, Fumio Ohtake, Norio Ohmagari, Ken Osaka, Mitsuo Kaku, Tomimasa Sunagawa, Kazutoshi Nakashima, Hiroshi Nishiura, Koji Wada, Shigeru Omi, Takaji Wakita

Abstract

To deal with the risk of emerging diseases with many unknowns, close and timely collaboration and communication between science experts and policymakers are crucial to developing and implementing an effective science-based intervention strategy. The Expert Meeting, an ad hoc medical advisory body, was established in February 2020 to advise Japan's COVID-19 Response Headquarters. The group played an important role in the policymaking process, promoting timely situation awareness and developing science-based proposals on interventions that were promptly reflected in government actions. However, this expert group may have been overly proactive in taking on the government's role in crisis management. For the next stage of managing the coronavirus disease pandemic and future pandemics, the respective roles of the government and its advisory bodies need to be clearly defined. Leadership and strategic risk communication by the government are key.

Keywords: COVID-19; Japan; SARS-CoV-2; communicable diseases; coronavirus disease; health communication; policy making; public health practice; respiratory infections; risk assessment; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
 
Back
Top Bottom